MBIO News and Press, Mustang Bio Inc.

2026-05-29 17:20:13 ET Read the full article on Seeking Alpha For further details see: Fortress Biotech: Is It Time To Pay The Deferred Preferred Stock Dividends?

2026-03-09 18:38:23 ET Mustang Bio, Inc. (MBIO) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 2.80%. The average open to low on the day of earnings was -6.93%. The average open to clos...

2026-03-09 18:33:24 ET Mustang Bio, Inc. (MBIO) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in MBIO stock price following earnings has averaged ±2.87% , with a median of 1.11%. Th...

Mustang Bio Inc. (MBIO) is expected to report for Q2 2025

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.ca News Commentary – Cancer rates are climbing across the U.S., with stark disparities from state to state. Recent CDC data shows Maine now leads the nation in cancer incidence, while...

2025-07-08 08:50:24 ET Palm Beach, FL – July 8, 2025 – The global oncology market, including breakthrough treatments, is experiencing substantial growth, with revenues projected to reach hundreds of billions of dollars in the coming years. Several factors are driving...

2025-07-07 14:30:42 ET Mustang Bio Rockets 218% After FDA Grants Orphan Drug Designation for CAR-T Therapy Mustang Bio Inc. ( MBIO ) soared 217.73%, dominating the PRISM Emerging Biotech Index , following the FDA's Orphan Drug Designation for MB-101 , its IL13Ra2-targeted ...

2025-07-07 12:43:08 ET Mustang Bio ( MBIO ) has secured a key regulatory milestone with the U.S. Food and Drug Administration granting Orphan Drug Designation for its investigational treatment MB-101. The therapy targets a rare group of aggressive brain cancers known as astrocytomas...

2025-07-07 11:16:29 ET Mustang Bio, Inc. (NASDAQ: MBIO) is one today’s most active stocks by volume. So far today, approximately 211.3M shares of Mustang Bio, Inc. have been exchanged, as compared to an average 30-day volume of 1.59M shares. Mustang Bio, Inc., a clinical-stag...

2025-07-07 09:45:53 ET DENVER, Colo., Jul 07, 2025 ( 247marketnews.com )- In a bold move to accelerate its national expansion, Venu (NYSE:VENU) appointed Terri Liebler as President of Growth and Strategy , a newly created executive role signaling the company’s intent ...